June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Caffeine preferentially protects against oxygen-induced retinopathy
Author Affiliations & Notes
  • Shuya Zhang
    School of Optometry and Ophthalmology, Wenzhou Medical University, Wenzhou, China
  • Rong Zhou
    School of Optometry and Ophthalmology, Wenzhou Medical University, Wenzhou, China
  • Bo Li
    School of Optometry and Ophthalmology, Wenzhou Medical University, Wenzhou, China
  • Haiyan Li
    School of Optometry and Ophthalmology, Wenzhou Medical University, Wenzhou, China
  • Cun Wang
    School of Optometry and Ophthalmology, Wenzhou Medical University, Wenzhou, China
  • Yanyan Wang
    School of Optometry and Ophthalmology, Wenzhou Medical University, Wenzhou, China
  • Xuejiao Gu
    School of Optometry and Ophthalmology, Wenzhou Medical University, Wenzhou, China
  • Dingjuan Zhong
    School of Optometry and Ophthalmology, Wenzhou Medical University, Wenzhou, China
  • Lingyun Tang
    School of Optometry and Ophthalmology, Wenzhou Medical University, Wenzhou, China
  • Yuanyuan Ge
    School of Optometry and Ophthalmology, Wenzhou Medical University, Wenzhou, China
  • Yuqing Huo
    Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta, Maine, United States
  • Jing Lin
    Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Xiao-Ling Liu
    School of Optometry and Ophthalmology, Wenzhou Medical University, Wenzhou, China
  • Jiang-Fan Chen
    School of Optometry and Ophthalmology, Wenzhou Medical University, Wenzhou, China
  • Footnotes
    Commercial Relationships   Shuya Zhang, None; Rong Zhou, None; Bo Li , None; Haiyan Li , None; Cun Wang , None; Yanyan Wang , None; Xuejiao Gu , None; Dingjuan Zhong, None; Lingyun Tang, None; Yuanyuan Ge, None; Yuqing Huo, None; Jing Lin , None; Xiao-Ling Liu , None; Jiang-Fan Chen , None
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 3670. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Shuya Zhang, Rong Zhou, Bo Li, Haiyan Li, Cun Wang, Yanyan Wang, Xuejiao Gu, Dingjuan Zhong, Lingyun Tang, Yuanyuan Ge, Yuqing Huo, Jing Lin, Xiao-Ling Liu, Jiang-Fan Chen; Caffeine preferentially protects against oxygen-induced retinopathy. Invest. Ophthalmol. Vis. Sci. 2017;58(8):3670.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The clinical observation of the reduced severity of retinopathy of prematurity (ROP) in premature infants after caffeine treatment for sleep apnea raises an exciting possibility that caffeine may protect against pathological retinal neovascularization in ROP via adenosine receptor antagonism. Using the oxygen-induced retinopathy (OIR) model of ROP in mice, we evaluated the efficacy, therapeutic window, the receptor and cellular mechanisms for caffeine to confer protection against OIR.

Methods : We treated the mice with caffeine (0.1-1.0 g/L) with four different treatment paradigms (P0-7, P7-12, P12-17 and P0-17 respectively). Retinal vascularization was examined by whole-mounted fluorescence and cross-sectional hematoxylin-eosin staining. Astrocyte activation and tip cell function in retina were determined by isolectin staining and immunohistochemistry. Retinal apoptosis was determined by TUNEL assay.

Results : Caffeine treatment from P0-P17 dose-dependently and selectively attenuated vaso-obliteration and pathological neovascularization in OIR without interfering normal retinal vascularization. The treatment of caffeine at P7-12 was effective in reducing vaso-obliteration by attenuating neuronal apoptosis while the treatment of caffeine at P7-12 as well as P12-17 was effective in reducing neovascularization by enhancing tip cell function in OIR. A1Rs was not involved in caffeine’s protection against OIR since A1R KO exacerbated OIR and administering caffeine to A1R KO still produced protection against OIR.Caffeine exerted protection against OIR at P12 by acting at the A2AR-dependent mechanism since both caffeine and A2AR KO produced similar and partial protection against OIR and the combined caffeine A2AR KO did not produced further protection. By contrast, caffeine conferred protection at P17 by A2AR-dependent as well as A2AR-independent mechanisms since the combined treatment of caffeine and A2AR produced additional and nearly full protection against OIR on the top of the partial protection by caffeine or A2AR KO alone.

Conclusions : We have demonstrated the preferential protection against OIR, therapeutic window and A2AR-dependent and A2AR-independent mechanisms of caffeine effects in mouse OIR model. Together with widely use of caffeine in neonate care, our findings provide the proof-of-principle evidence to translate the novel caffeine therapy for prevention and treatment of ROP.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×